Lupin protein isolate and cysteine-supplemented casein reduce calcification of atherosclerotic lesions in apoE-deficient mice

British Journal of Nutrition

Volumn 103, Issue 2, 2010, Pages 180-188

  Weisse, Kristin ^a   Brandsch, Corinna ^a   Hirche, Frank ^a   Eder, Klaus ^a   Stangl, Gabriele I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ApoE deficient mice; Atherosclerotic lesions; Cysteine; Lupin protein

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; CASEIN; COLLAGEN; CYSTEINE; FAT; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUPIN PROTEIN; MINERAL; OVALBUMIN; PHOSPHATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; 5' NUCLEOTIDASE; AMINO ACID; CYSTINE; LIPID; NT5C3 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DIET; PROTEIN ISOLATION; ANIMAL; ANIMAL FOOD; BLOOD; CALCINOSIS; CALORIC INTAKE; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PROTEIN INTAKE;

ANIMALIA; MUS;

5'-NUCLEOTIDASE; AMINO ACIDS; ANIMAL FEED; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CALCINOSIS; CASEINS; CYSTINE; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENERGY INTAKE; LIPIDS; MICE; MICE, KNOCKOUT; TRIGLYCERIDES;

EID: 75549091197     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991565     Document Type: Article

References (50)

1. Petterson DS (1998) Composition and food uses of lupins. Lupins as Crop Plants: Biology, Production, and Utilization, pp. 353-384 [JS Gladstones, CA Atkins and J Hamblin, editors]. Wallingford, UK: CAB International.
2. Xiao CW, Mei J & Wood CM (2008) Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression. Front Biosci 13, 2660-2673.
3. Sirtori CR, Lovati MR, Manzoni C, et al. (2004) Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J Nutr 134, 18-23.
4. Marchesi M, Parolini C, Diani E, et al. (2008) Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model. Br J Nutr 100, 707-710.
5. Bettzieche A, Brandsch C, Weisse K, et al. (2008) Lupin protein influences the expression of hepatic gene involved in fatty acid synthesis and triacylglycerol hydrolysis of adult rats. Br J Nutr 99, 952-962.
6. Spielmann J, Shukla A, Brandsch C, et al. (2007) Dietary lupin protein lowers triglyceride concentrations in liver and plasma in rats by reducing hepatic gene expression of sterol regulatory element-binding protein-1c. Ann Nutr Metab 51, 387-392.
7. Nakashima Y, Plump AS, Raines EW, et al. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14, 133-140.
8. Zhang SH, Reddick RL, Piedrahita JA, et al. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471.
9. Shukla A, Brandsch C, Bettzieche A, et al. (2007) Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes. J Nutr Biochem 18, 313-321.
10. Yang L, Kumagai T, Kawamura H, et al. (2007) Effects of rice proteins from two cultivars, Koshihikari and Shunyo, on cholesterol and triglyceride metabolism in growing and adult rats. Biosci Biotechnol Biochem 71, 694-703.
11. Nagarajan S, Burris RL, Stewart BW, et al. (2008) Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipopro-tein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 138, 332-337.
12. Sanchez A & Hubbard RW (1991) Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses 36, 27-32.
13. Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125, 606S-611S.
14. Shukla A, Bettzieche A, Hirche F, et al. (2006) Dietary fish protein alters blood lipid concentrations and hepatic genes involved in cholesterol homeostasis in the rat model. Br J Nutr 96, 674-682.
15. Lin CC, Yin MC, Hsu CC, et al. (2004) Effect of five cysteine-containing compounds on three lipogenic enzymes in Balb/cA mice consuming a high saturated fat diet. Lipids 39, 843-848.
16. Lin CC & Yin MC (2008) Effects of cysteine-containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet. Br J Nutr 99, 37-43.
17. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 123, 1939-1951.
18. Wäsche A, Müller K & Knauf U (2001) New processing of lupin protein isolates and functional properties. Nahrung 45, 393-395.
19. Sung JH, Choi SJ, Lee SW, et al. (2004) Isoflavones found in Korean soybean paste as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Biosci Biotechnol Biochem 68, 1051-1058.
20. Teupser D, Persky AD & Breslow JL (2003) Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 23, 1907-1913.
21. 2/2 mice despite severe hypercholesterolemia. Atherosclerosis 198, 39-48.
22. Vester B & Rasmussen K (1991) High performance liquid chro-matography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Bio-chem 29, 549-554.
23. Levander OA, Deloach DP, Morris VC, et al. (1983) Platelet glutathione peroxidase activity as an index of selenium status in rats. J Nutr 113, 55-63.
24. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
25. Raith K, Brunner C, Farwanah H, et al. (2005) A new LC/APCI-MS method for the determination of cholesterol oxidation products in food. J Chromatogr A 1067, 207-211.
26. Burkhard I, Rentsch KM & von Eckardstein A (2004) Determination of 24S-and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. J Lipid Res 45, 776-781.
27. National Research Council (1985) Guide for the Care and Use of Laboratory Animals. Publication no. 85-123 (rev.). Washington, DC: National Institutes of Health.
28. Ketteler M & Giachelli C (2006) Novel insights into vascular calcification. Kidney Int Suppl. 105, S5-S9.
29. Greenwald SE (2007) Ageing of the conduit arteries. J Pathol 211, 157-172.
30. Abedin M, Tintut Y & Demer LL (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24, 1161-1170.
31. Doherty TM & Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54, 224-230.
32. Virmani R, Burke AP, Kolodgie FD, et al. (2003) Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 16, 267-272.
33. Ehara S, Kobayashi Y, Yoshiyama M, et al. (2004) Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110, 3424-3429.
34. Vengrenyuk Y, Carlier S, Xanthos S, et al. (2006) A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA 103, 14678-14683.
35. Towler DA, Shao JS, Cheng SL, et al. (2006) Osteogenic regulation of vascular calcification. Ann N Y Acad Sci 1068, 327-333.
36. Byon CH, Javed A, Dai Q, et al. (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor runx-2 by akt signaling. J Biol Chem 283, 15319-15327.
37. Hirose N, Arai Y, Ishii T, et al. (2001) Association of mild hyperhomocysteinemia with aortic calcification in hypercholes-terolemic patients. J Atheroscler Thromb 8, 91-94.
38. Tang FT, Chen SR, Wu XQ, et al. (2006) Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress. Calcif Tissue Int 79, 326-339.
39. Tankó LB, Bagger YZ, Qin G, et al. (2005) Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111, 1883-1890.
40. Ni W, Tsuda Y, Sakono M, et al. (1998) Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr 128, 1884-1889.
41. Alrasadi K, Alwaili K, Awan Z, et al. (2009) Aortic calcifications in familial hypercholesterolemia: potential role of the low-density lipoprotein receptor gene. Am Heart J 157, 170-176.
42. Caudarella R, Vescini F, Buffa A, et al. (2007) Hyperphospha-temia: effects on bone metabolism and cardiovascular risk. J Endocrinol Invest 30, 29-34.
43. Shioi A & Nishizawa Y (2009) Roles of hyperphosphatemia in vascular calcification. Clin Calcium 19, 180-185.
44. Duell PB & Malinow MR (1997) Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 8, 28-34.
45. Meister A & Anderson ME (1983) Glutathione. Annu Rev Biochem 52, 711-760.
46. Ookhtens M & Kaplowitz N (1998) Role of the liver in interor-gan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18, 313-329.
47. Mosharov E, Cranford MR & Banerjee T (2000) The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39, 13005-13011.
48. Watson KE, Boström K, Ravindranath R, et al. (1994) TGF-b1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93, 2106-2113.
49. Shao JS, Aly ZA, Lai CF, et al. (2007) Vascular Bmp Msx2 Wnt signalling and oxidative stress in arterial calcification. Ann N Y Acad Sci 1117, 40-50.
50. Brown AJ & Jessup W (1999) Oxysterols and atherosclerosis. Atherosclerosis 142, 1-28.